<i>In Vitro</i> Susceptibility of Gram-Negative Pathogens to Cefiderocol in Five Consecutive Annual Multinational SIDERO-WT Surveillance Studies, 2014 to 2019
James A. Karlowsky, Meredith A. Hackel, Miki Takemura +3
Antimicrobial Agents and Chemotherapy
Infections and bacterial resistance
We report <i>in vitro</i> susceptibility data from five consecutive annual SIDERO-WT surveillance studies (2014 to 2019) for cefiderocol and comparators tested against Gram-negative clinical isolates...